Provided by Tiger Trade Technology Pte. Ltd.

Aytu BioScience, Inc.

2.39
+0.09003.91%
Volume:42.89K
Turnover:103.48K
Market Cap:25.65M
PE:-1.05
High:2.50
Open:2.30
Low:2.28
Close:2.30
52wk High:3.07
52wk Low:0.9500
Shares:10.73M
Float Shares:5.69M
Volume Ratio:0.36
T/O Rate:0.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2773
EPS(LYR):-2.1596
ROE:-109.23%
ROA:-0.22%
PB:1.81
PE(LYR):-1.11

Loading ...

Analysts Offer Insights on Healthcare Companies: Bio-Techne (TECH) and Aytu BioScience (AYTU)

TIPRANKS
·
Feb 05

Aytu BioPharma Insider Buyers Net US$87k Despite 10% Stock Decline

Simply Wall St.
·
Feb 05

Aytu Biopharma stellt neue Unternehmenspräsentation mit Fokus auf Therapien für Depression und ADHS vor

Reuters
·
Feb 04

Aytu BioPharma Q2 revenue beats expectations

Reuters
·
Feb 04

Aytu BioPharma Q2 EPS $(1.05) Misses $(0.49) Estimate, Sales $15.165M Beat $12.174M Estimate

Benzinga
·
Feb 04

Aytu Biopharma meldet für das zweite Quartal (Q2) 2026 einen Nettoverlust von USD 10,58 Mio. und einen Rückgang des bereinigten EBITDA um 163 Prozent auf USD -0,80 Mio

Reuters
·
Feb 04

Aytu Biopharma Q2 Gross Profit USD 9.624 Million

THOMSON REUTERS
·
Feb 04

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Feb 02

Aytu Biopharma Inc. to Report Second Quarter Results and Host Conference Call

Reuters
·
Jan 28

Analysts Are Bullish on These Healthcare Stocks: Butterfly Network (BFLY), Aytu BioScience (AYTU)

TIPRANKS
·
Jan 21

Aytu Biopharma Hosts Investor Day Highlighting EXXUA Launch Strategy

Reuters
·
Jan 21

Aytu Biopharma Unveils EXXUA Launch and Clinical Data for Major Depressive Disorder

Reuters
·
Jan 21

Aytu BioPharma CEO to Join Lytham Partners Investor Healthcare Summit

Reuters
·
Jan 14

Aytu Biopharma Hosts Investor Day Spotlighting EXXUA for Major Depressive Disorder

Reuters
·
Jan 12

Aytu BioPharma, Inc. (NASDAQ:AYTU) Stock Catapults 28% Though Its Price And Business Still Lag The Industry

Simply Wall St.
·
Dec 20, 2025

Aytu Biopharma Inc. held annual shareholder meeting

Reuters
·
Dec 11, 2025

Aytu BioPharma Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
Dec 10, 2025

Aytu BioPharma Presents at Noble Capital Markets Emerging Growth Equity Conference

Reuters
·
Nov 25, 2025

Aytu Biopharma Unveils Strategic Focus on CNS Therapeutics and EXXUA Launch in Latest Corporate Presentation

Reuters
·
Nov 19, 2025

Aytu BioScience (AYTU) Gets a Buy from Lake Street

TIPRANKS
·
Nov 14, 2025